NCT04176926View on ClinicalTrials.gov

Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch

CompletedOBSERVATIONAL
Enrollment

472

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

March 2, 2020

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Electrocardiogram

Diagnostic Test: Simultaneous assessment of heart rhythm by 12-lead ECG and wearable device characterization of heart rhythm.

Trial Locations (10)

20010

MedStar Washington Hospital Center, Washington D.C.

27804

PMG Research of Rocky Mount, Rocky Mount

28401

PMG Research of Wilmington, Wilmington

28625

PMG Research of Piedmont Healthcare, Statesville

29407

PMG Research of Charleston, Mt. Pleasant

32162

Bioclinica Research The Villages, The Villages

32806

Bioclinica Research Orlando, Orlando

50010

PMG Research of McFarland, Ames

60190

PMG Research of Dupage, Winfield

Unknown

Onassis Cardiac Surgery Center, Kallithea

All Listed Sponsors
lead

Fitbit LLC

INDUSTRY

NCT04176926 - Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch | Biotech Hunter | Biotech Hunter